VistaPharm, Inc. recalls Nystatin Oral Suspension, USP, 100,000 units/mL, packaged in a) 2 fl.oz. (60mL) bottles (NDC 66689-008-02), and 500,000…
- Recall date
- May 17, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0869-2017
- FDA classification
- Class III
- Brand / firm
- VistaPharm, Inc.
- Sold / distributed
- Nationwide in the US and Puerto Rico
Why it was recalled
Failed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Nystatin Oral Suspension, USP, 100,000 units/mL, packaged in a) 2 fl.oz. (60mL) bottles (NDC 66689-008-02), and 500,000 units/5mL individual unit dose cup (NDC 66689-037-01) packaged in b) 50 count unit dose cups/case (NDC 66689-037-50) and c) 100 count unit dose cups/case (NDC 66689-037-99) Rx only, Manufactured by: VistaPharm, Largo, FL 33771.
Get recall alerts
Free email alert whenever VistaPharm, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: VistaPharm, Inc.